+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Rituximab Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

Rituximab Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
NUCALA Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

NUCALA Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Dupilumab Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

Dupilumab Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Romiplate Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Romiplate Sales Forecast and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
XEOMIN Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

XEOMIN Sales Forecast and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
DYSPORT Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

DYSPORT Sales Forecast and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
From
Lipodystrophy - Pipeline Insight, 2026 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
COSENTYX Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

COSENTYX Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Huntington'S Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Huntington'S Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 80 Pages
  • Global
From
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Diabetic Macular Edema - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Candidiasis - Pipeline Insight, 2026 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Primary Biliary Cholangitis - Pipeline Insight, 2026 - Product Thumbnail Image

Primary Biliary Cholangitis - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 80 Pages
  • Global
From
Pyoderma Gangrenosum - Pipeline Insight, 2026 - Product Thumbnail Image

Pyoderma Gangrenosum - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2026 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Wilson Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Wilson Disease - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2026 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more